Genedata Screener Holds Global User Group Meetings for Innovations in Screening Data Analysis
News Sep 12, 2012
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, has announced its User Group Meetings will be held in Asia, Europe, and North America during the fall 2012. Annual meetings bring together scientists, lab heads, bioinformaticians, and research IT managers from leading pharmaceutical and biotechnology companies, academic institutions, and contract research organizations. The sessions, which feature industry experts and forward-thinking customer presentations, explore the latest developments in high-throughput screening (HTS), high content screening (HCS), and label-free and Ion Channel data analysis.
"I am proud to say that Genedata Screener® has become the de facto standard for screening laboratories that value very fast and efficient data analysis for a variety of screening applications," said Dr. Othmar Pfannes, CEO of Genedata. "This year's User Group Meetings, conducted across three continents, validate Screener's global adoption and we are delighted to provide forums in which leading scientists can network, learn and discuss about the latest developments in different screening technologies and applications.
The 2012 Genedata Screener User Group Meetings will offer workshops and training sessions on topics such as: from raw data to high-quality hit lists; analyzing Ion Channel experiments; selecting features in HCS assays; and conducting batch workflows. Meetings will be held in: Tokyo, Japan (Sept. 13); Boston, MA (Oct. 23); San Francisco, CA (Oct. 25); and Basel, Switzerland (Nov. 6). Inquiries may be sent to: firstname.lastname@example.org.
Computational Model Underlines Need for Personalised Approach to SepsisNews
A computational model of the human immune system has enabled researchers to explore the challenges of tackling sepsis.READ MORE
Enamine and BioSolveIT Launch the World's Largest Searchable Chemical Space for Novel Compound SourcingNews
REAL Space Navigator offers access to over 640 million pharma-oriented compounds.READ MORE